• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核细胞衍生的巨噬细胞促成肌萎缩侧索硬化症中的几丁质酶失调:一项初步研究。

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study.

作者信息

Gaur Nayana, Huss Elena, Prell Tino, Steinbach Robert, Guerra Joel, Srivastava Akash, Witte Otto W, Grosskreutz Julian

机构信息

Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.

Jena Centre for Healthy Ageing, Jena University Hospital, Jena, Germany.

出版信息

Front Neurol. 2021 May 14;12:629332. doi: 10.3389/fneur.2021.629332. eCollection 2021.

DOI:10.3389/fneur.2021.629332
PMID:34054686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8160083/
Abstract

Neuroinflammation significantly contributes to Amyotrophic Lateral Sclerosis (ALS) pathology. In lieu of this, reports of elevated chitinase levels in ALS are interesting, as they are established surrogate markers of a chronic inflammatory response. While post-mortem studies have indicated glial expression, the cellular sources for these moieties remain to be fully understood. Therefore, the objective of this pilot study was to examine whether the peripheral immune system also contributes to chitinase dysregulation in ALS. The temporal expression of CHIT1, CHI3L1, and CHI3L2 in non-polarized monocyte-derived macrophages (MoMas) from ALS patients and healthy controls (HCs) was examined. We demonstrate that while CHIT1 and CHI3L1 display similar temporal expression dynamics in both groups, profound between-group differences were noted for these targets at later time-points i.e., when cells were fully differentiated. CHIT1 and CHI3L1 expression were significantly higher in MoMas from ALS patients at both the transcriptomic and protein level, with CHI3L1 levels also being influenced by age. Conversely, CHI3L2 expression was not influenced by disease state, culture duration, or age. Here, we demonstrate for the first time, that in ALS, circulating immune cells have an intrinsically augmented potential for chitinase production that may propagate chronic neuroinflammation, and how the ageing immune system itself contributes to neurodegeneration.

摘要

神经炎症在肌萎缩侧索硬化症(ALS)的病理过程中起着重要作用。鉴于此,ALS患者中几丁质酶水平升高的报道很有意思,因为它们是慢性炎症反应的既定替代标志物。虽然尸检研究表明胶质细胞有表达,但这些分子的细胞来源仍有待充分了解。因此,本初步研究的目的是检验外周免疫系统是否也在ALS中导致几丁质酶失调。研究了来自ALS患者和健康对照(HC)的非极化单核细胞衍生巨噬细胞(MoMas)中CHIT1、CHI3L1和CHI3L2的时间表达情况。我们证明,虽然CHIT1和CHI3L1在两组中表现出相似的时间表达动态,但在较晚的时间点,即细胞完全分化时,这些靶点在组间存在显著差异。在转录组和蛋白质水平上,ALS患者的MoMas中CHIT1和CHI3L1的表达均显著更高,CHI3L1水平也受年龄影响。相反,CHI3L2的表达不受疾病状态、培养时间或年龄的影响。在此,我们首次证明,在ALS中,循环免疫细胞具有内在增强的几丁质酶产生潜力,这可能会加剧慢性神经炎症,以及衰老的免疫系统本身如何导致神经退行性变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/8160083/ddf7ebb6af46/fneur-12-629332-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/8160083/e84ae2817bf2/fneur-12-629332-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/8160083/ddf7ebb6af46/fneur-12-629332-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/8160083/e84ae2817bf2/fneur-12-629332-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359f/8160083/ddf7ebb6af46/fneur-12-629332-g0002.jpg

相似文献

1
Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study.单核细胞衍生的巨噬细胞促成肌萎缩侧索硬化症中的几丁质酶失调:一项初步研究。
Front Neurol. 2021 May 14;12:629332. doi: 10.3389/fneur.2021.629332. eCollection 2021.
2
CSF chitinase proteins in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的 CSF 几丁质酶蛋白。
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1215-1220. doi: 10.1136/jnnp-2019-320442. Epub 2019 May 23.
3
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的脑脊液巨噬细胞生物标志物。
Ann Neurol. 2018 Feb;83(2):258-268. doi: 10.1002/ana.25143. Epub 2018 Feb 9.
4
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者症状出现前后的 CSF 几丁质酶。
Ann Clin Transl Neurol. 2020 Aug;7(8):1296-1306. doi: 10.1002/acn3.51114. Epub 2020 Jul 14.
5
Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.几丁质酶作为肌萎缩侧索硬化症的潜在诊断和预后生物标志物:系统评价和荟萃分析。
Neurol Sci. 2024 Jun;45(6):2489-2503. doi: 10.1007/s10072-024-07301-5. Epub 2024 Jan 9.
6
The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond.几丁质酶作为肌萎缩侧索硬化症的生物标志物:来自中枢神经系统及其他方面的信号
Front Neurol. 2020 May 27;11:377. doi: 10.3389/fneur.2020.00377. eCollection 2020.
7
Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis.脑脊液几丁质酶作为肌萎缩侧索硬化症的生物标志物
Diagnostics (Basel). 2021 Jul 5;11(7):1210. doi: 10.3390/diagnostics11071210.
8
CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients.肌动蛋白 3L1 和肌动蛋白 3L2 在运动皮层和脊髓中的过表达与 sALS 患者相关。
Mol Cell Neurosci. 2017 Dec;85:162-169. doi: 10.1016/j.mcn.2017.10.001. Epub 2017 Oct 6.
9
Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes.肌萎缩侧索硬化症中几丁质酶蛋白的横断面和纵向测量及活化星形胶质细胞中 CHI3L1 的表达。
J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):350-358. doi: 10.1136/jnnp-2019-321916. Epub 2020 Jan 14.
10
Determination of chitinases family during osteoclastogenesis.测定破骨细胞分化过程中的几丁质酶家族。
Bone. 2014 Apr;61:55-63. doi: 10.1016/j.bone.2014.01.005. Epub 2014 Jan 16.

引用本文的文献

1
Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive Review.几丁质酶-3样蛋白1在人体多个系统中的炎症效应及调节机制:综述
Int J Mol Sci. 2024 Dec 15;25(24):13437. doi: 10.3390/ijms252413437.
2
The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets.亨廷顿舞蹈病中的微生物群-肠-脑轴:致病机制与治疗靶点
FEBS J. 2025 Mar;292(6):1282-1315. doi: 10.1111/febs.17102. Epub 2024 Mar 1.
3
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations.

本文引用的文献

1
Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.神经酰胺三己糖苷酶,肌萎缩侧索硬化症的生物标志物,通过神经炎症加重脊髓运动神经元的神经退行性变。
J Neuroinflammation. 2020 Aug 6;17(1):232. doi: 10.1186/s12974-020-01909-y.
2
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者症状出现前后的 CSF 几丁质酶。
Ann Clin Transl Neurol. 2020 Aug;7(8):1296-1306. doi: 10.1002/acn3.51114. Epub 2020 Jul 14.
3
The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond.
肌萎缩侧索硬化症的尿液生物标志物:候选物、机遇与考量
Brain Commun. 2023 Oct 24;5(6):fcad287. doi: 10.1093/braincomms/fcad287. eCollection 2023.
4
Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma.抑制巨噬细胞特异性 CHIT1 作为治疗严重哮喘气道重塑的一种方法。
Int J Mol Sci. 2023 Mar 1;24(5):4719. doi: 10.3390/ijms24054719.
5
Identification of an immune-related gene prognostic index for predicting prognosis, immunotherapeutic efficacy, and candidate drugs in amyotrophic lateral sclerosis.鉴定一种免疫相关基因预后指数,用于预测肌萎缩侧索硬化症的预后、免疫治疗疗效及候选药物。
Front Cell Neurosci. 2022 Dec 15;16:993424. doi: 10.3389/fncel.2022.993424. eCollection 2022.
6
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19.接受 CAR T19 治疗的 B 细胞 ALL 患者的细胞因子释放综合征和免疫效应细胞相关神经毒性综合征的综合血清蛋白质组谱分析。
Clin Cancer Res. 2022 Sep 1;28(17):3804-3813. doi: 10.1158/1078-0432.CCR-22-0822.
7
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的炎症的基于血液的生物标志物。
Mol Neurodegener. 2022 Jan 24;17(1):11. doi: 10.1186/s13024-022-00515-1.
几丁质酶作为肌萎缩侧索硬化症的生物标志物:来自中枢神经系统及其他方面的信号
Front Neurol. 2020 May 27;11:377. doi: 10.3389/fneur.2020.00377. eCollection 2020.
4
Increased activation ability of monocytes from ALS patients.肌萎缩侧索硬化症患者单核细胞的激活能力增强。
Exp Neurol. 2020 Jun;328:113259. doi: 10.1016/j.expneurol.2020.113259. Epub 2020 Feb 24.
5
Chitinases, neuroinflammation and biomarkers in ALS.肌萎缩侧索硬化症中的几丁质酶、神经炎症与生物标志物
J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):338. doi: 10.1136/jnnp-2019-322520. Epub 2020 Jan 14.
6
Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis.将 D50 疾病进展模型应用于肌萎缩侧索硬化症的灰、白质病理学。
Neuroimage Clin. 2020;25:102094. doi: 10.1016/j.nicl.2019.102094. Epub 2019 Nov 28.
7
Sex difference in CHI3L1 expression levels in human brain aging and in Alzheimer's disease.人脑衰老和阿尔茨海默病中 CHI3L1 表达水平的性别差异。
Brain Res. 2019 Oct 1;1720:146305. doi: 10.1016/j.brainres.2019.146305. Epub 2019 Jun 24.
8
CSF chitinase proteins in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的 CSF 几丁质酶蛋白。
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1215-1220. doi: 10.1136/jnnp-2019-320442. Epub 2019 May 23.
9
Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase.不同临床阶段的肌萎缩侧索硬化症和额颞叶痴呆的神经炎症特征不同。
J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):4-10. doi: 10.1136/jnnp-2018-318868. Epub 2018 Sep 17.
10
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的脑脊液巨噬细胞生物标志物。
Ann Neurol. 2018 Feb;83(2):258-268. doi: 10.1002/ana.25143. Epub 2018 Feb 9.